Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tony Hawkridge

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Vaccine|April 30, 2011
Phenotypic variability in childhood TB: implications for diagnostic endpoints in tuberculosis vaccine trialsHumphrey Mulenga, Sizulu Moyo, Lesley Workman, et al.
Bulletin of the World Health Organization|May 1, 2010
Structured approaches for the screening and diagnosis of childhood tuberculosis in a high prevalence region of South AfricaMark Hatherill, Monique Hanslo, Tony Hawkridge, et al.
The Pediatric Infectious Disease Journal|November 30, 2006
The impact of a change in bacille Calmette-Guérin vaccine policy on tuberculosis incidence in children in Cape Town, South AfricaHassan Mahomed, Maurice Kibel, Tony Hawkridge, et al.
AIDS Research and Human Retroviruses|April 12, 2011
HIV-specific gag responses in early infancy correlate with clinical outcome and inversely with viral loadBongeka Nqoko, Cheryl L Day, Nazma Mansoor, et al.
Tuberculosis (Edinburgh, Scotland)|March 13, 2013
Screening for TB in high school adolescents in a high burden setting in South AfricaHassan Mahomed, Rodney Ehrlich, Tony Hawkridge, et al.
Plos One|March 28, 2013
TB incidence in an adolescent cohort in South AfricaHassan Mahomed, Rodney Ehrlich, Tony Hawkridge, et al.
BMC Infectious Diseases|December 4, 2014
Serum indoleamine 2,3-dioxygenase activity is associated with reduced immunogenicity following vaccination with MVA85ARachel Tanner, Kristina Kakalacheva, Ellen Miller, et al.
The Journal of Infectious Diseases|June 28, 2008
Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in healthy adults in South AfricaTony Hawkridge, Thomas J Scriba, Sebastian Gelderbloem, et al.
Lancet (London, England)|March 28, 2016
A blood RNA signature for tuberculosis disease risk: a prospective cohort studyDaniel E Zak, Adam Penn-Nicholson, Thomas J Scriba, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Vaccine|April 30, 2011
Phenotypic variability in childhood TB: implications for diagnostic endpoints in tuberculosis vaccine trialsHumphrey Mulenga, Sizulu Moyo, Lesley Workman, et al.
Bulletin of the World Health Organization|May 1, 2010
Structured approaches for the screening and diagnosis of childhood tuberculosis in a high prevalence region of South AfricaMark Hatherill, Monique Hanslo, Tony Hawkridge, et al.
The Pediatric Infectious Disease Journal|November 30, 2006
The impact of a change in bacille Calmette-Guérin vaccine policy on tuberculosis incidence in children in Cape Town, South AfricaHassan Mahomed, Maurice Kibel, Tony Hawkridge, et al.
AIDS Research and Human Retroviruses|April 12, 2011
HIV-specific gag responses in early infancy correlate with clinical outcome and inversely with viral loadBongeka Nqoko, Cheryl L Day, Nazma Mansoor, et al.
Tuberculosis (Edinburgh, Scotland)|March 13, 2013
Screening for TB in high school adolescents in a high burden setting in South AfricaHassan Mahomed, Rodney Ehrlich, Tony Hawkridge, et al.
Plos One|March 28, 2013
TB incidence in an adolescent cohort in South AfricaHassan Mahomed, Rodney Ehrlich, Tony Hawkridge, et al.
BMC Infectious Diseases|December 4, 2014
Serum indoleamine 2,3-dioxygenase activity is associated with reduced immunogenicity following vaccination with MVA85ARachel Tanner, Kristina Kakalacheva, Ellen Miller, et al.
The Journal of Infectious Diseases|June 28, 2008
Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in healthy adults in South AfricaTony Hawkridge, Thomas J Scriba, Sebastian Gelderbloem, et al.
Lancet (London, England)|March 28, 2016
A blood RNA signature for tuberculosis disease risk: a prospective cohort studyDaniel E Zak, Adam Penn-Nicholson, Thomas J Scriba, et al.
Pageof 2